Clinical Trial Update: Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates dosing of Nuwiq (octocog alfa) and related outcomes for surgical management in women and girls with Hemophilia A. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Nuwiq (recombinant factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Hemophilia A | Phase 4 | Status: RECRUITING